Rick Wise
Stock Analyst at Stifel
(4.40)
# 316
Out of 4,883 analysts
237
Total ratings
65.28%
Success rate
11.63%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $92.19 | +24.74% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $172.75 | +29.67% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $52.03 | +5.71% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $133.11 | +8.93% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $14.15 | +97.88% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $21.45 | +49.18% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $45.52 | +31.82% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $30.15 | -0.50% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $31.54 | +52.19% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $103.46 | +15.99% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 → $90 | $76.56 | +17.55% | 23 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $390.96 | +12.54% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $155.07 | -0.05% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $534.11 | +14.21% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $162.51 | +16.92% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $29.63 | +28.25% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $6.04 | +32.45% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $2.63 | +508.37% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $76.36 | +7.39% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $74.57 | +36.78% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $87.48 | -0.55% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.09 | +97.04% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $82.96 | -9.59% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $16.12 | +48.88% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $20.47 | +339.78% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $11.75 | +112.77% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $58.32 | +92.04% | 5 | Oct 2, 2020 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $92.19
Upside: +24.74%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $172.75
Upside: +29.67%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $52.03
Upside: +5.71%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $133.11
Upside: +8.93%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $14.15
Upside: +97.88%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $21.45
Upside: +49.18%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $45.52
Upside: +31.82%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $30.15
Upside: -0.50%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $31.54
Upside: +52.19%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $103.46
Upside: +15.99%
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $76.56
Upside: +17.55%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $390.96
Upside: +12.54%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $155.07
Upside: -0.05%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $534.11
Upside: +14.21%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $162.51
Upside: +16.92%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $29.63
Upside: +28.25%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $6.04
Upside: +32.45%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $2.63
Upside: +508.37%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $76.36
Upside: +7.39%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $74.57
Upside: +36.78%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $87.48
Upside: -0.55%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.09
Upside: +97.04%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $82.96
Upside: -9.59%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $16.12
Upside: +48.88%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $20.47
Upside: +339.78%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $11.75
Upside: +112.77%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $58.32
Upside: +92.04%